Variant report
Variant | rs8105636 |
---|---|
Chromosome Location | chr19:43385630-43385631 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:160)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr19:43385477-43385698 | GM19240 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
2 | CTCF | chr19:43385580-43385730 | A549 | lung: | n/a | chr19:43385580-43385589 |
3 | SPI1 | chr19:43385513-43385658 | K562 | blood: | n/a | n/a |
4 | E2F6 | chr19:43385486-43385725 | K562 | blood: | n/a | n/a |
5 | CTCF | chr19:43385480-43385630 | NHEK | skin: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
6 | CTCF | chr19:43385520-43385670 | AG10803 | skin: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
7 | MAX | chr19:43385433-43385911 | HCT-116 | colon: | n/a | n/a |
8 | MYC | chr19:43385626-43385635 | MCF-7 | breast: | n/a | n/a |
9 | MAX | chr19:43385385-43385967 | A549 | lung: | n/a | n/a |
10 | CTCF | chr19:43385520-43385670 | GM12875 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
11 | CTCF | chr19:43385460-43385690 | GM12878 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
12 | CTCF | chr19:43385500-43385650 | GM12866 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
13 | CTCF | chr19:43385480-43385700 | MCF-7 | breast: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
14 | CTCF | chr19:43385500-43385710 | GM10266 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
15 | CTCF | chr19:43385500-43385650 | HPF | lung: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
16 | CBX3 | chr19:43385431-43385838 | K562 | blood: | n/a | n/a |
17 | CTCF | chr19:43385501-43385662 | GM13976 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
18 | CTCF | chr19:43385466-43385707 | GM19239 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
19 | CTCF | chr19:43385435-43385704 | MCF-7 | breast: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
20 | CTCF | chr19:43385466-43385686 | GM13977 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
21 | CTCF | chr19:43385264-43385912 | SK-N-SH | brain: | n/a | chr19:43385382-43385390 chr19:43385580-43385589 chr19:43385574-43385592 |
22 | EBF1 | chr19:43385412-43385716 | GM12878 | blood: | n/a | chr19:43385541-43385550 |
23 | CTCF | chr19:43385227-43385793 | K562 | blood: | n/a | chr19:43385382-43385390 chr19:43385580-43385589 chr19:43385574-43385592 |
24 | MAX | chr19:43385525-43385749 | K562 | blood: | n/a | n/a |
25 | CTCF | chr19:43385540-43385690 | WERI-Rb-1 | eye: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
26 | CTCF | chr19:43385498-43385683 | LNCaP | prostate: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
27 | CTCF | chr19:43385480-43385630 | Caco-2 | colon: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
28 | CTCF | chr19:43385580-43385730 | WI-38 | lung: | n/a | chr19:43385580-43385589 |
29 | CTCF | chr19:43385500-43385650 | AG09319 | gingival: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
30 | CTCF | chr19:43385477-43385703 | A549 | lung: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
31 | RAD21 | chr19:43385427-43385726 | IMR90 | lung: | n/a | chr19:43385572-43385591 |
32 | CTCF | chr19:43385520-43385670 | GM12801 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
33 | SMC3 | chr19:43385501-43385647 | K562 | blood: | n/a | n/a |
34 | CTCF | chr19:43385251-43386015 | A549 | lung: | n/a | chr19:43385382-43385390 chr19:43385580-43385589 chr19:43385574-43385592 |
35 | CTCF | chr19:43385540-43385690 | MCF-7 | breast: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
36 | CTCF | chr19:43385450-43385716 | GM12891 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
37 | RAD21 | chr19:43385458-43385709 | Hela-S3 | cervix: | n/a | chr19:43385572-43385591 |
38 | CTCF | chr19:43385520-43385670 | AG04449 | skin: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
39 | CTCF | chr19:43385454-43385725 | K562 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
40 | SMC3 | chr19:43385466-43385715 | Hela-S3 | cervix: | n/a | n/a |
41 | CTCF | chr19:43385620-43385770 | NHDF-neo | bronchial: | n/a | n/a |
42 | RXRA | chr19:43385442-43385928 | HepG2 | liver: | n/a | chr19:43385572-43385592 |
43 | CTCF | chr19:43385600-43385750 | HVMF | connective: | n/a | n/a |
44 | CTCF | chr19:43385500-43385650 | NHEK | skin: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
45 | ZNF263 | chr19:43385380-43385663 | HEK293-T-REx | kidney: | n/a | chr19:43385423-43385432 |
46 | CTCF | chr19:43385230-43385804 | A549 | lung: | n/a | chr19:43385382-43385390 chr19:43385580-43385589 chr19:43385574-43385592 |
47 | CTCF | chr19:43385520-43385670 | HCPEpiC | choroid plexus: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
48 | CTCF | chr19:43385425-43385745 | K562 | blood: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
49 | CTCF | chr19:43385520-43385670 | HPAF | blood vessel: | n/a | chr19:43385580-43385589 chr19:43385574-43385592 |
50 | MAX | chr19:43385400-43385768 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PSG1 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10164400 | 0.82[EUR][1000 genomes] |
rs10401410 | 0.80[ASN][1000 genomes] |
rs10401981 | 0.89[ASN][1000 genomes] |
rs10403207 | 0.91[ASN][1000 genomes] |
rs10404617 | 0.84[AMR][1000 genomes];0.98[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10405119 | 0.92[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs10405156 | 0.87[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs10405430 | 0.94[ASN][1000 genomes] |
rs10405854 | 0.85[AFR][1000 genomes];0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10406210 | 0.85[ASN][1000 genomes] |
rs10406979 | 0.80[EUR][1000 genomes] |
rs10408171 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs10408392 | 0.94[ASN][1000 genomes] |
rs10409077 | 0.89[ASN][1000 genomes] |
rs10409273 | 0.89[ASN][1000 genomes] |
rs10409602 | 0.87[AFR][1000 genomes];0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs10410502 | 0.81[EUR][1000 genomes] |
rs10410760 | 0.81[AMR][1000 genomes];0.84[ASN][1000 genomes] |
rs10410940 | 0.82[ASN][1000 genomes] |
rs10411688 | 0.90[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10412183 | 0.87[AFR][1000 genomes];0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10413496 | 0.91[ASN][1000 genomes] |
rs10413609 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs10413886 | 0.91[ASN][1000 genomes] |
rs10414325 | 0.92[AMR][1000 genomes];0.95[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs10414577 | 0.85[EUR][1000 genomes] |
rs10414706 | 0.93[ASN][1000 genomes] |
rs10415444 | 0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10415640 | 0.85[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10415716 | 0.82[ASN][1000 genomes] |
rs10416723 | 0.89[ASN][1000 genomes] |
rs10417214 | 0.90[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs10417364 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10420213 | 0.81[ASN][1000 genomes] |
rs10420788 | 0.80[ASN][1000 genomes] |
rs10420838 | 0.82[ASN][1000 genomes] |
rs10421663 | 0.94[ASN][1000 genomes] |
rs10421724 | 0.85[ASN][1000 genomes] |
rs10421738 | 0.82[ASN][1000 genomes] |
rs10421952 | 0.82[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10422367 | 0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10422417 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10422560 | 0.88[AFR][1000 genomes];0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs10422635 | 0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs10423067 | 0.94[ASN][1000 genomes] |
rs10423122 | 0.86[ASN][1000 genomes] |
rs10423732 | 0.91[ASN][1000 genomes] |
rs10423757 | 0.91[ASN][1000 genomes] |
rs10424257 | 0.84[AMR][1000 genomes];0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs10424427 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10426517 | 0.92[AMR][1000 genomes];0.95[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs10426946 | 0.92[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1058817 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs1064491 | 0.91[ASN][1000 genomes] |
rs1065178 | 0.90[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs11083666 | 0.89[ASN][1000 genomes] |
rs1141653 | 0.94[ASN][1000 genomes] |
rs12459171 | 0.92[ASN][1000 genomes] |
rs12459252 | 0.97[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs12459271 | 0.91[ASN][1000 genomes] |
rs12459344 | 0.96[ASN][1000 genomes] |
rs12460750 | 0.89[ASN][1000 genomes] |
rs12460851 | 0.96[ASN][1000 genomes] |
rs12461039 | 0.95[ASN][1000 genomes] |
rs12462092 | 0.83[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs12462903 | 0.94[ASN][1000 genomes] |
rs12463041 | 0.94[ASN][1000 genomes] |
rs12463071 | 0.95[ASN][1000 genomes] |
rs13346001 | 0.91[ASN][1000 genomes] |
rs13346193 | 0.83[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs13346199 | 0.83[AMR][1000 genomes];0.95[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs1811214 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs1962302 | 0.89[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs1962303 | 0.89[ASN][1000 genomes] |
rs1966371 | 0.94[ASN][1000 genomes] |
rs1985620 | 0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs1985621 | 0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.97[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs1987627 | 0.91[ASN][1000 genomes] |
rs1987696 | 0.90[ASN][1000 genomes] |
rs1987697 | 0.89[ASN][1000 genomes] |
rs1987698 | 0.82[AFR][1000 genomes];0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1988065 | 0.91[ASN][1000 genomes] |
rs1989986 | 0.83[EUR][1000 genomes] |
rs2041107 | 0.90[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs2041108 | 0.89[ASN][1000 genomes] |
rs2074856 | 0.87[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2074857 | 0.87[ASN][1000 genomes] |
rs2107457 | 0.83[EUR][1000 genomes] |
rs2108488 | 0.90[AFR][1000 genomes];0.91[AMR][1000 genomes];0.92[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2108526 | 0.94[ASN][1000 genomes] |
rs2353116 | 0.91[ASN][1000 genomes] |
rs2354271 | 0.93[ASN][1000 genomes] |
rs28374299 | 0.89[ASN][1000 genomes] |
rs28376612 | 0.80[ASN][1000 genomes] |
rs28409818 | 0.86[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs28412804 | 0.84[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs28427189 | 0.84[EUR][1000 genomes] |
rs28435082 | 0.87[AMR][1000 genomes];0.96[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs28489113 | 0.80[ASN][1000 genomes] |
rs28542917 | 0.82[EUR][1000 genomes] |
rs28579274 | 0.91[ASN][1000 genomes] |
rs28624202 | 0.89[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs28790593 | 0.89[ASN][1000 genomes] |
rs2883096 | 0.88[EUR][1000 genomes] |
rs3198831 | 0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs3199707 | 0.91[ASN][1000 genomes] |
rs34045026 | 0.82[ASN][1000 genomes] |
rs34078108 | 0.82[ASN][1000 genomes] |
rs36072603 | 0.80[ASN][1000 genomes] |
rs3827010 | 0.94[ASN][1000 genomes] |
rs4075680 | 0.80[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4263043 | 0.88[ASN][1000 genomes] |
rs4346296 | 0.82[ASN][1000 genomes] |
rs4366810 | 0.81[AMR][1000 genomes];0.93[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4380148 | 0.95[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4430863 | 0.88[AFR][1000 genomes];0.92[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4500870 | 0.86[EUR][1000 genomes] |
rs4520942 | 0.91[ASN][1000 genomes] |
rs4536565 | 0.86[ASN][1000 genomes] |
rs4538113 | 0.81[AMR][1000 genomes];0.88[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs4538114 | 0.87[AMR][1000 genomes];0.98[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs4621087 | 0.82[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs4621088 | 0.91[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs4624304 | 0.81[AFR][1000 genomes];0.82[AMR][1000 genomes];0.89[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs55698945 | 0.80[ASN][1000 genomes] |
rs55771336 | 0.80[ASN][1000 genomes] |
rs57201124 | 0.80[ASN][1000 genomes] |
rs62110890 | 0.94[ASN][1000 genomes] |
rs62110892 | 0.91[ASN][1000 genomes] |
rs62110909 | 0.89[ASN][1000 genomes] |
rs62110911 | 0.88[ASN][1000 genomes] |
rs62110917 | 0.82[ASN][1000 genomes] |
rs62110918 | 0.82[ASN][1000 genomes] |
rs62112987 | 0.91[ASN][1000 genomes] |
rs62112988 | 0.87[ASN][1000 genomes] |
rs62112989 | 0.88[ASN][1000 genomes] |
rs62112990 | 0.85[ASN][1000 genomes] |
rs62112992 | 0.87[ASN][1000 genomes] |
rs6509033 | 0.82[EUR][1000 genomes] |
rs6509034 | 0.91[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs6509037 | 0.83[AMR][1000 genomes];0.83[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6509038 | 0.87[AMR][1000 genomes];0.83[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6509040 | 0.85[AMR][1000 genomes];0.95[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7248431 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7250910 | 0.87[AMR][1000 genomes];0.97[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs7251720 | 0.83[AMR][1000 genomes];0.89[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs7251938 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs7253121 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7254080 | 0.88[AFR][1000 genomes];0.95[AMR][1000 genomes];0.97[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7255788 | 0.82[ASN][1000 genomes] |
rs7258262 | 0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7260004 | 0.80[EUR][1000 genomes] |
rs73035282 | 0.94[ASN][1000 genomes] |
rs758095 | 0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs8100095 | 0.90[AMR][1000 genomes];0.88[ASN][1000 genomes] |
rs8100982 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs8101010 | 0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs8102265 | 0.86[AFR][1000 genomes];0.85[AMR][1000 genomes];0.96[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs8103585 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs8104427 | 0.97[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs8105685 | 0.91[AFR][1000 genomes];0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs8107681 | 0.83[AMR][1000 genomes];0.97[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs8108042 | 0.91[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs8108570 | 0.87[EUR][1000 genomes] |
rs8110746 | 0.87[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs8110938 | 0.83[AFR][1000 genomes];0.98[AMR][1000 genomes];0.91[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs8111114 | 0.87[AFR][1000 genomes];0.99[AMR][1000 genomes];0.96[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs8111438 | 0.82[EUR][1000 genomes] |
rs8111762 | 0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.96[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs8111915 | 0.82[ASN][1000 genomes] |
rs8112263 | 0.82[EUR][1000 genomes] |
rs8113148 | 0.82[ASN][1000 genomes] |
rs9304613 | 0.82[EUR][1000 genomes] |
rs9304614 | 0.81[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs9304615 | 0.83[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs9304616 | 0.86[AMR][1000 genomes];0.98[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs9676609 | 0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv2422471 | chr19:42733141-43669485 | Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 70 gene(s) | inside rSNPs | diseases |
2 | esv2422468 | chr19:42991289-43669027 | Enhancers Weak transcription Strong transcription Active TSS Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
3 | esv2758501 | chr19:43042747-43899053 | Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
4 | esv2758763 | chr19:43042747-43899053 | Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
5 | nsv428023 | chr19:43042747-43899053 | Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
6 | esv2422227 | chr19:43059426-43669485 | Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 20 gene(s) | inside rSNPs | diseases |
7 | nsv1056270 | chr19:43139043-43542819 | Enhancers Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
8 | nsv544007 | chr19:43141984-43529861 | Strong transcription Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
9 | nsv1061798 | chr19:43141984-43741311 | Flanking Active TSS Enhancers Weak transcription Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 20 gene(s) | inside rSNPs | diseases |
10 | nsv544008 | chr19:43141984-43741311 | Enhancers Weak transcription Strong transcription Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 20 gene(s) | inside rSNPs | diseases |
11 | esv2754239 | chr19:43145417-43559330 | Flanking Active TSS Enhancers Strong transcription Weak transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
12 | esv1845826 | chr19:43152829-43454902 | Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
13 | esv2757697 | chr19:43164418-43870887 | Enhancers Weak transcription Strong transcription Bivalent Enhancer Active TSS Genic enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
14 | nsv1055872 | chr19:43173614-44075193 | Strong transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 43 gene(s) | inside rSNPs | diseases |
15 | nsv544009 | chr19:43173614-44075193 | Enhancers ZNF genes & repeats Genic enhancers Active TSS Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 43 gene(s) | inside rSNPs | diseases |
16 | nsv544010 | chr19:43173814-43584478 | Weak transcription Enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
17 | nsv544011 | chr19:43173814-43741311 | Enhancers Weak transcription Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
18 | esv2751786 | chr19:43198035-43685930 | Enhancers Active TSS Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
19 | nsv516973 | chr19:43202770-43866823 | Active TSS Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
20 | nsv869916 | chr19:43203105-43584433 | Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
21 | nsv869571 | chr19:43203105-43802656 | Enhancers Weak transcription Active TSS Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
22 | nsv869565 | chr19:43203105-43810421 | Enhancers Weak transcription Strong transcription Bivalent Enhancer Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 20 gene(s) | inside rSNPs | diseases |
23 | nsv963056 | chr19:43203249-43798708 | Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Strong transcription Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
24 | nsv9730 | chr19:43203459-43802656 | Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
25 | esv1812820 | chr19:43203937-43803388 | Genic enhancers Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer ZNF genes & repeats Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
26 | esv1808074 | chr19:43214215-43805847 | Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
27 | esv1813803 | chr19:43214415-43805651 | Active TSS ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
28 | esv2763121 | chr19:43215328-43846394 | Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
29 | nsv833835 | chr19:43220207-43423373 | Weak transcription Enhancers Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
30 | nsv428364 | chr19:43220207-43435444 | Enhancers Weak transcription Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
31 | esv1846846 | chr19:43225921-43774853 | Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
32 | esv1805299 | chr19:43227458-43790318 | Enhancers Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
33 | nsv1060654 | chr19:43228125-43451808 | Enhancers Weak transcription Strong transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
34 | nsv911810 | chr19:43233048-43629573 | Enhancers Weak transcription Genic enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
35 | esv2760524 | chr19:43237611-43805328 | Enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
36 | nsv1061598 | chr19:43237764-43415712 | Enhancers Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
37 | esv34661 | chr19:43240379-43673190 | Weak transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Active TSS Flanking Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
38 | esv2751787 | chr19:43240379-43685930 | Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
39 | esv2751788 | chr19:43240379-43711592 | Enhancers Weak transcription Active TSS Flanking Active TSS ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
40 | nsv432049 | chr19:43240379-43711592 | Weak transcription Enhancers ZNF genes & repeats Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
41 | esv2751789 | chr19:43240379-43731159 | Enhancers Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
42 | nsv432050 | chr19:43240379-43777571 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Active TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
43 | esv2751790 | chr19:43240379-43805328 | Enhancers Active TSS Weak transcription Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
44 | nsv529148 | chr19:43242595-43530001 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
45 | nsv1067715 | chr19:43242795-43741310 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
46 | nsv529386 | chr19:43242795-43741310 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
47 | nsv916162 | chr19:43242811-43529887 | Enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
48 | nsv916623 | chr19:43242811-43584499 | Enhancers Weak transcription Genic enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
49 | nsv497975 | chr19:43242811-43741714 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
50 | nsv911811 | chr19:43247348-43806559 | Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:43381600-43386000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr19:43381600-43386200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr19:43381600-43386200 | Weak transcription | NHEK | skin |
4 | chr19:43381600-43387000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
5 | chr19:43382200-43389000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
6 | chr19:43384000-43389000 | Weak transcription | NHDF-Ad | bronchial |
7 | chr19:43384400-43386200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr19:43384400-43388400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
9 | chr19:43384400-43389000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr19:43385600-43387600 | Enhancers | HMEC | breast |
11 | chr19:43385600-43388600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr19:43385600-43388600 | Weak transcription | Placenta | Placenta |